Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

Yıldırım, Mahmut EmreKaraca, MustafaArtaç, MehmetÇiçin, İrfanGeredeli, ÇağlayanAlacacıoğlu, AhmetTanrıkulu Şimşek, EdaBilici, AhmetHarputluoğlu, HakanÖzçelik, MelikeBozkurt, OktayYüksel, SinemişTural, DenizSakin, AbdullahÇil, TimuçinÖven, Bala BaşakDane, FaysalÇevik, DuyguGümüş, MahmutIşıkdogan, Abdurrahman2022-11-072022-11-072022Yıldırım, M. E., Karaca, M., Artaç, M., Çiçin, İ., Geredeli, Ç., Alacacıoğlu, A. ... Işıkdogan, A. (2022). Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC. Journal of Clinical Oncology içinde (E15562-E15562. ss.).0732-183X1527-7755https://hdl.handle.net/20.500.12511/9935[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessBiologics Second-Line mCRCTreatment Outcomes FromOnco-colon Turkey RegistryReal-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRCConference Object4016E15562E15562Q1000863680303045